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Purpose: To evaluate the effect of lens status on intraocular pressure (IOP) in siliconized eyes 
and also on the emulsification of silicone oil.
Patients and methods: A total of 31 eyes of 31 patients with retinal detachment were 
operated on with pars plana vitrectomy and silicone oil injection: 16 phakic (Group A) and 
15 pseudophakic (Group B). During the 6-month follow-up period, IOP was measured: 1 day 
postoperative, then at 1 week, 1 month, 2 months, 3 months, and 6 months postoperative. At 
the end of the follow-up period, gonioscopy was carried out to check emulsified silicone at the   
anterior chamber angle and also the presence of emulsified silicone on the back of the cornea 
when the patient was lying down.
Results: There was no significant difference between both groups until the first week 
(P value = 0.15). Starting from the first month, the difference was statistically significant, with 
mean IOPs in Groups A and B of 14.9 mmHg and 18.2 mmHg, respectively, up to the sixth 
month (P value = 0.002), with a mean IOP in Groups A and B of 14.4 mmHg and 19.4 mmHg, 
respectively. Emulsified silicone was clinically stated in twelve cases (80%) in Group B and in 
three cases (19%) in Group A.
Conclusion: There is a higher incidence of increased IOP and emulsification of silicone oil in 
pseudophakic eyes than in phakic eyes.
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Introduction
The use of silicone oil in conjunction with advanced vitreous surgical techniques can 
successfully treat complicated retinal detachment (RD),1–4 including proliferative 
vitreoretinopathy (PVR), giant retinal tears, and severe trauma cases.5,6
Silicone oil is still the best-tolerated substance that is well accepted and biologi-
cally well tolerated in the clinical management of complicated conditions. Although 
it is well recognized that aphakic patients may develop pupil block glaucoma after 
vitrectomy and silicone oil injection,7,8 this condition is not well recognized in phakic 
patients.9,10
Furthermore, hypotony is especially common after posterior segment retinal reat-
tachment surgery for PVR. Chronic hypotony was found in 58 (24.1%) of 241 eyes 
in a silicone study11 and in 41(17.5%) of 234 eyes in the Vitreon study.12 There are 
likely multiple, complex reasons for this finding, but one potential contributory fac-
tor may be the presence of a native or prosthetic intraocular lens. The lens and lens 
diaphragm can serve as potential physical impediments to the complete dissection of 
anterior tractional membranes and the vitreous base.
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The aim of this study was to assess the influence of 
postoperative lens status on the intraocular pressure (IOP) 
changes in eyes treated with silicone oil in the management 
of complicated RD.
Patients and methods
We performed a prospective, comparative study, which was 
carried out during the period from March 2010 to April 2011. 
This study included 31 eyes (16 phakic and 15   pseudophakic) 
of 31 patients: 18 males and 13 females. These 31 eyes 
underwent pars plana vitrectomy for repair of RD resulting 
from PVR, with silicone oil 1000 cSt as endotamponade. This 
study was carried out at Kasr El Eini University   Hospital, 
Cairo, Egypt. The mean age was 42 ± 0.6 years (range 
20–63 years).
Informed consent was obtained from all patients after 
they received a detailed description of the surgical   procedure. 
Exclusion criteria included severe systemic disease, 
  pregnancy, any pre-existing ocular inflammatory disease, 
glaucoma, or recurrent cases of RD.
The following preoperative and postoperative parameters 
were noticed: etiology of RD, refractive status, pre-existing glau-
coma, lens status, presence of emulsified silicone in the anterior 
chamber, emulsification of silicone, and rubeosis iridis.
Additionally, all the study patients received full   preoperative 
and postoperative examinations 1 day after surgery and then 
at 1-week, 1-month, 2-month, 3-month, and 6-month follow-
ups. These examinations included IOP measurement using 
  Goldmann applanation tonometer, slit-lamp examination, 
dilated ophthalmologic examination, and best-corrected visual 
acuity using a Snellen chart.
At the end of the follow-up period, gonioscopy was 
  carried out to check emulsified silicone at the anterior cham-
ber angle and also the presence of emulsified silicone on the 
back of the cornea when the patient was lying down during 
the operative procedure under the operating microscope.
Fundus photography was done preoperatively and at the 
end of the follow-up period, to ascertain the C/D ratio. The 
presence of ocular hypertension was defined as postopera-
tively elevated IOP greater than 25 mmHg.
All surgeries were performed under general anesthesia. 
The surgical procedure included a standard three-port pars 
plana vitrectomy using the ACCURUS® system (Alcon Labo-
ratories, Inc, Hünenberg, Switzerland) for vitrectomy.   During 
vitrectomy, the vitreous base was thoroughly removed. 
Epiretinal membrane dissection and relaxing retinotomies 
were performed, when necessary. The retinal periphery was 
inspected for retinal breaks, and any break found was treated 
with endolaser photocoagulation. A fluid–air exchange 
procedure was then performed. At the end of the surgical 
  procedure, silicone oil was injected using an automatic 
device. The silicone used was of 1000 cSt viscosity at 25°C, 
with a specific gravity of 0.965 g/cm3, and interfacial tension 
against water at 25°C of 35.5 mN/m.
At the end of surgery, the eye appeared clinically   completely 
filled by the substance. Suture of the sclerotomies followed. In 
all cases, the surgery was not combined with scleral buckle 
placement, and no intraoperative   complications occurred.
Postoperative follow-up examinations were scheduled, as 
mentioned previously, and all the data collected were used 
for statistical analysis.
Statistical analysis was carried out using SPSS for 
  Windows (v 17.0; SPSS, Inc, Chicago, IL), and P values of 
less than 0.05 were considered statistically significant.
Results
Thirty-one eyes of 31 patients with RD were operated on with 
pars plana vitrectomy and silicone oil injection: 16 phakic 
(Group A) and 15 pseudophakic (Group B).
The average patient age at time of surgery was 42 ± 0.6 years 
(range 20–63 years). The   postoperative   follow-up period was 
6 months. No intraoperative   complications were encountered 
during the operative procedure.
During the 6-month follow-up period, IOP was   measured 
on the first day postoperative then at 1 week, 1 month, 
2 months, 3 months, and 6 months postoperative.
Group A had rhegmatogenous RD, with 12 cases with 
PVR graded as C2 with Machemer classification and four 
cases graded as C3.13
Group B had pseudophakic RD, with three cases 
graded as C2 and twelve cases graded as C3 by Machemer 
classification.
Postoperative follow-up included a full clinical   examination. 
Cases of recurrent RD were excluded from the study.
Comparing the results of IOP pressure measurement 
showed that there was no statistically significant differ-
ence between Group A (mean IOP = 14.8 mmHg) and 
Group B (mean IOP = 16 mmHg) in the first day postopera-
tive (P value = 0.1).
Comparing IOP measurements at the first week postoper-
ative was also of no statistically significant difference: Group 
A mean IOP = 15 mmHg, Group B mean IOP = 16.2 mmHg 
(P value = 0.15), as seen in Table 1.
Starting from the first month to the sixth month, the dif-
ference was statistically significant between the two groups, 
as shown in Table 2.
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Figure 1 also shows the mean IOP measurements of 
both groups during the first, second, third, and sixth months 
postoperative.
Regarding C/D ratio, there was no change of more than 
0.1 in three cases (20%) in Group B. In Group A there was 
no change in C/D ratio throughout the follow-up period.
Emulsified silicone was found on the back of the cornea 
when the patient was lying down or by gonioscopy in twelve 
cases in Group B (80%), whereas in Group A, emulsified 
silicone was detected in only three cases (19%).
During silicone evacuation in Group A, eleven cases 
(68.7%) had a clinically significant cataract that needed 
extraction.
Discussion
Silicone oil is an effective intraocular tamponade. It is often 
placed in the vitreoretinal cavity as an aid in the repair of 
PVR, proliferative diabetic retinopathy, recurrent RD, giant 
retinal tears, macular holes, viral retinitis, and traumatic 
retinal injuries.14
However, the use of silicone oil as endotamponade may 
be associated with an increased incidence of elevated IOP. 
The cause of raised IOP following the use of endotamponade 
in the surgical treatment of complicated RD may be mul-
tifactorial, including inflammation, previous vitreoretinal 
procedures, and overfilling.15 Clinically significant increased 
IOP could represent a complication following vitreoretinal 
procedures, which can lead to the development of secondary 
glaucoma.16,17
In a study performed by Henderer et al,18 it was reported 
that 21% (80 out of 383 eyes) of patients treated with 
  silicone oil for complex RD had an elevated IOP (greater 
than 25 mmHg) at the 12-month follow-up.
In our study, a mild increase in IOP was noticed. 
This increase was more pronounced in Group B   (pseudophakic 
RD group) than in Group A (phakic RD group), of which 
the difference which was not statistically significant on the 
first day and after the first week postoperative (P = 0.1 and 
P = 0.15, respectively) but became statistically significant 
during the first, second, third, and sixth month postop-
erative (P = 0.02, P = 0.008, P = 0.003, and P = 0.002, 
respectively).
Emulsification of silicone oil to some degree has been 
reported to occur in 56%–100% of cases over a period 
of months to years.19,20 Multiple factors may contribute 
to silicone oil emulsification, including the use of low-
viscosity silicone oils, residual fluid in the vitreous cavity, 
and hemorrhage or leakage of other blood constituents from 
the breakdown of the blood–aqueous barrier after surgery. 
Even the oil/aqueous movement generated by high-speed 
vitrectomy handpieces results in shearing force in silicone 
oil emulsification.21,22
In our study, emulsified silicone was found in twelve 
cases (80%) in Group B, whereas in Group A, only three 
cases were detected (19%).
The increased incidence of silicone emulsification in 
Group B, and also the higher IOP measurements postopera-
tively in comparison with Group A, may be related to the 
fact that when the silicone oil emulsifies, it may induce a 
chronic reaction.
The macrophages react toward the tamponade emulsion 
as if it were a foreign body, as already reported by Hiscott 
et al23 in 2001, for F6H8, and thus they are able to promote, 
theoretically, an IOP increase. However, no explanation could 
be given to relate the increased incidence of   emulsification in 
Table 1 Mean intraocular pressure (IOP) measurements of both 






First day postoperative 14.8 mmHg 16 mmHg 0.1
First week postoperative 15 mmHg 16.2 mmHg 0.15
Table  2  Mean  intraocular  pressure  (IOP)  measurements  of 







First month 14.9 mmHg 18.2 mmHg 0.02
Second month 14.4 mmHg 17.8 mmHg 0.008
Third month 14.6 mmHg 19.3 mmHg 0.003
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Figure 1 Mean intraocular pressure (IOP) measurements of both groups during the 
first, second, third, and sixth month postoperative.
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cases of pseudophakic pars plana vitrectomy more than the 
phakic, and a larger number of cases are required in further 
studies to prove this relationship.
Also, there was a higher incidence of cataract   progression 
in phakic patients of Group A (68.7%) who needed cataract 
extraction during silicone oil removal. This was described 
by another study, which described a higher incidence 
of   progressive, clinically significant cataract following 
vitrectomy.24
Conclusion
This study illustrates the possible influence of lens status on 
IOP outcomes in eyes that underwent successful repair of 
RD by pars plana vitrectomy and silicone oil tamponading. 
Higher IOP measurements were detected in   pseudophakic 
patients; thus, ophthalmologists should be aware that 
  incidence of glaucoma may occur in pseudophakic patients 
more than in phakic patients after vitrectomy and silicone 
oil injection.
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